SCHEMBL721372

SCHEMBL721372

CC1CC2C3CCC(C3)C2CC1=O

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA4 P22748 1/20 0.32
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31673503 1.00 CA1 (0.32) CA1CA2CA4KMT2A
SCHEMBL29633172 1.00 CA1 (0.32) CA1CA2CA4KMT2A
SCHEMBL19922315 1.00 CA1 (0.32) CA1CA2CA4KMT2A
SCHEMBL29633252 1.00 CA1 (0.32) CA1CA2CA4KMT2A
SCHEMBL17627695 1.00 CA1 (0.32) CA1CA2CA4KMT2A
SCHEMBL9238452 1.00 CA1 (0.32) CA1CA2CA4KMT2A
SCHEMBL9381726 0.73 MAPK1 (0.33)
SCHEMBL9639468 0.72
SCHEMBL9506330 0.72
SCHEMBL17691143 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 732 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4711010-A2 PRO-PERFUME COMPOSITIONS Firmenich SA (CH) 2026-03-18 EP claimed
US-20260068882-A1 ARTHROPOD CONTROLLING COMPOSITION FIRMENICH & CIE (CH) 2026-03-12 US claimed
US-12398341-B2 Apparatus and compositions for improving scent delivery THE PROCTER & GAMBLE COMPANY (US) 2025-08-26 US claimed
CN-113905612-B Arthropod control composition 弗门尼舍有限公司 2025-04-08 CN claimed
WO-2025051371-A1 A FRAGRANCE PASTILLE SYMRISE AG (DE) 2025-03-13 WO claimed
EP-4519404-A1 METHODS FOR ENHANCING MENTAL PERFORMANCE AND COMPOSITIONS FOR USE THEREIN Firmenich SA (CH) 2025-03-12 EP claimed
US-12247180-B2 Apparatus and compositions for improving scent delivery THE PROCTER & GAMBLE COMPANY (US) 2025-03-11 US claimed
WO-2025045353-A1 A FRAGRANCE POD SYMRISE AG (DE) 2025-03-06 WO claimed
WO-2025045354-A1 A FRAGRANCE TABLET SYMRISE AG (DE) 2025-03-06 WO claimed
CN-119403908-A Method for enhancing psychological performance and composition for use in the method 弗门尼舍有限公司 2025-02-07 CN claimed
WO-2013029963-A1 PROCESS FOR CONTROLLING MALODORS USING OXAZOLIDINES HENKEL AG & CO. KGAA (DE) 2013-03-07 WO claimed
WO-2012084292-A1 PERFUME COMPOSITION COMPRISING FRAGRANCE ALDEHYDE OR KETONE AND OXAZOLIDINE FRAGRANCE PRECURSOR HENKEL AG & CO. KGAA (DE) 2012-06-28 WO claimed
EP-2020225-A2 Fragrance composition Kao Corporation (JP) 2009-02-04 EP claimed
US-20080118591-A1 mixture contains perfume ingredients active against gramnegative bacteria; alcohols, aldehydes, ketones, imines, esters compound; low concentrations of Triclosan or other phenolic biocides; for disinfection, cleaning; liquid soaps for washing, shampoo; oral care products, mouth wash, tooth paste GIVAUDAN SA (CH) 2008-05-22 US claimed
EP-1853214-A1 BACTERICIDAL FORMULATIONS Givaudan SA (CH) 2007-11-14 EP claimed
WO-2006053458-A1 BACTERICIDAL FORMULATIONS GIVAUDAN SA (CH) 2006-05-26 WO claimed
US-20050245407-A1 Fragrance composition KAO CORPORATION (JP) 2005-11-03 US claimed
EP-1552814-A1 FRAGRANCE COMPOSITION Kao Corporation (JP) 2005-07-13 EP claimed
EP-0678497-B1 Composition containing a preponderant amount of (1RS,5RS)-5-methyl-exo-tricyclo[6.2.1.0 2,7]undecan-4-one and its use in parfumery FIRMENICH & CIE (CH) 1998-01-21 EP claimed
EP-0678497-A1 Composition containing a preponderant amount of (1RS,5RS)-5-methyl-exo-tricyclo 6.2.1.0 2,7 undecan-4on and its use in parfumery FIRMENICH SA (CH) 1995-10-25 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260068882-A1 ARTHROPOD CONTROLLING COMPOSITION CNOT9, MSL1, MT-CO2 CA1 1607/4885CA2 1318/4885CA4 1089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.